TP53 and Miyoshi myopathy: Co-occurrence of del17p with a TP53 mutation on the second allele – detected in around 6-8% of MM patients at the time of diagnosis - results in a bi-allelic inactivation and complete loss of p53 that is reportedly accompanied with worse outcomes compared to mono-allelic inactivations (187, 188).